Evidence map›Paper›PMID 26678224›Full record

ArticleCarcinogenesis2016

Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice.

Ralph A Pietrofesa, Anastasia Velalopoulou, Evguenia Arguiri, Craig W Menges, Joseph R Testa, Wei-Ting Hwang, Steven M Albelda, Melpo Christofidou-Solomidou

Open access · hybridAbstract read
In one paragraph

Article in Carcinogenesis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. The promising antioxidant effects of lignans: Nrf2 activation comes into view.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ralph A Pietrofesa
Anastasia Velalopoulou
Evguenia Arguiri
Craig W MengesCancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA and.
Joseph R TestaCancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA and.
Wei-Ting HwangDepartment of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Steven M Albelda
Melpo Christofidou-Solomidou
Fox Chase Cancer Center · USUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
Environmental Science Project 3 - Social Determinants of Risk and Attitudes AboutP42ES023720 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2014 to 2018
$11.3M
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXLR01CA175691 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI RAUSCHER III, FRANK JOSEPH, TESTA, JOSEPH R. · 2014 to 2018
$2.7M
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation PheumonopathyR01CA133470 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOFIDOU-SOLOMIDOU, MELPO · 2008 to 2012
$2.2M
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATIONR21AT008291 · NCCIH · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOFIDOU-SOLOMIDOU, MELPO, WINKELSTEIN, BETH A · 2015 to 2016
$440k
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)R03CA180548 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOFIDOU-SOLOMIDOU, MELPO · 2013 to 2014
$137k
NCCIH NIH HHS 1R21AT008291-02NCCIH NIH HHS R21 AT008291NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA016520NCI NIH HHS R01 CA133470NCI NIH HHS R01 CA175691NCI NIH HHS R03 CA180548NIEHS NIH HHS 1P30 ES013508-02NIEHS NIH HHS 1P42ES023720-01NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P42 ES023720
6 · The paper itself

Abstract

Malignant mesothelioma (MM), linked to asbestos exposure, is a highly lethal form of thoracic cancer with a long latency period, high mortality and poor treatment options. Chronic inflammation and oxidative tissue damage caused by asbestos fibers are linked to MM development. Flaxseed lignans, enriched in secoisolariciresinol diglucoside (SDG), have antioxidant, anti-inflammatory and cancer chemopreventive properties. As a prelude to chronic chemoprevention studies for MM development, we tested the ability of flaxseed lignan component (FLC) to prevent acute asbestos-induced inflammation in MM-prone Nf2(+/mu) mice. Mice (n = 16-17 per group) were placed on control (CTL) or FLC-supplemented diets initiated 7 days prior to a single intraperitoneal bolus of 400 µg of crocidolite asbestos. Three days post asbestos exposure, mice were evaluated for abdominal inflammation, proinflammatory/profibrogenic cytokine release, WBC gene expression changes and oxidative and nitrosative stress in peritoneal lavage fluid (PLF). Asbestos-exposed mice fed CTL diet developed acute inflammation, with significant (P < 0.0001) elevations in WBCs and proinflammatory/profibrogenic cytokines (IL-1ß, IL-6, TNFα, HMGB1 and active TGFß1) relative to baseline (BL) levels. Alternatively, asbestos-exposed FLC-fed mice had a significant (P < 0.0001) decrease in PLF WBCs and proinflammatory/profibrogenic cytokine levels relative to CTL-fed mice. Importantly, PLF WBC gene expression of cytokines (IL-1ß, IL-6, TNFα, HMGB1 and TGFß1) and cytokine receptors (TNFαR1 and TGFßR1) were also downregulated by FLC. FLC also significantly (P < 0.0001) blunted asbestos-induced nitrosative and oxidative stress. FLC reduces acute asbestos-induced peritoneal inflammation, nitrosative and oxidative stress and may thus prove to be a promising agent in the chemoprevention of MM.

Indexed as

AnimalsAntioxidantsAsbestos, CrocidoliteButylene GlycolsChromatography, LiquidDietDietary SupplementsDisease Models, AnimalEnzyme-Linked Immunosorbent AssayFlaxGlucosidesInflammationLignansMesotheliomaMiceMice, Mutant StrainsAntioxidantsAsbestos, CrocidoliteButylene GlycolsGlucosidesLignanssecoisolariciresinol diglucoside

Identifiers

PMID26678224
PMCPMC4745643
OpenAlexW2211952525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.